Edap Tms (NASDAQ:EDAP) Lowered to Neutral Rating by Piper Sandler

Piper Sandler downgraded shares of Edap Tms (NASDAQ:EDAP) from an overweight rating to a neutral rating in a research note released on Thursday, MarketBeat.com reports.

EDAP has been the subject of a number of other research reports. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price objective (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. StockNews.com initiated coverage on Edap Tms in a report on Thursday. They issued a “hold” rating for the company. Finally, HC Wainwright reiterated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research report on Friday, March 28th.

Edap Tms Stock Performance

Shares of EDAP stock opened at $1.76 on Thursday. Edap Tms has a 52-week low of $1.26 and a 52-week high of $7.00. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The stock has a market cap of $65.30 million, a PE ratio of -2.71 and a beta of 0.13. The business has a 50-day simple moving average of $1.93 and a 200-day simple moving average of $2.26.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, May 15th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts expect that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

Institutional investors have recently modified their holdings of the stock. Illumine Investment Management LLC acquired a new position in shares of Edap Tms during the 4th quarter worth about $50,000. Jane Street Group LLC increased its stake in Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the last quarter. Finally, Cetera Investment Advisers lifted its position in shares of Edap Tms by 33.9% in the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock valued at $147,000 after acquiring an additional 19,000 shares in the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.